Kyntra Bio Inc - Company Profile
Powered by 
All the sales intelligence you need on Kyntra Bio Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Kyntra Bio Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Kyntra Bio Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Kyntra Bio Inc (Kyntra) is a biopharmaceutical company that discovers, develops, and commercialises medicines based on hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology for addressing the unmet medical needs of anemia in chronic kidney disease and idiopathic pulmonary fibrosis. Focus on R&D, the lead product candidate, Roxadustat and existing collaborations are its strengths, even as the history of operating losses could be a major cause for concern for the company. Kyntra could benefit from regulatory approvals, the market potential of pancreatic cancer and a Robust R&D Pipeline. However, dependence on third-party manufacturers, stiff competition, and stringent regulations could affect the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer